Medicina Webinar | Onco-Surgical Approach to Peritoneal Malignancies — When, How, and to Whom?
the chairs
10th Medicina Webinar
Onco-Surgical Approach to Peritoneal Malignancies — When, How, and to Whom?
Dear colleagues,
It is an honor for us to host this webinar, titled “Onco-surgical approach to peritoneal malignancies—when, how, and to whom?”, on behalf of Medicina.
This webinar aims to offer a comprehensive overview of surgical procedures intending to cure both primary peritoneal malignancies and peritoneal metastases (mainly from ovarian and digestive cancers). Since these patients need a multidisciplinary approach to significantly prolong their lives, experienced surgeons and oncologists will join this meeting to discuss the updates in onco-surgical management of these patients. Beyond current therapeutic standards, the speakers will present updated evidence about unresolved issues such as the use of HIPEC, the optimal extent of cytoreductive surgery, its specific indications, and the best timing of the surgery with respect to systemic chemotherapy.
This webinar is addressed not only to surgeons and oncologists, but also to the gastroenterologists, gynecologists, pathologists, and general practitioners, because the recent advances in this field have dramatically improved the survival of such patients considered until recently as candidates for palliative therapy alone.
Date: 28 January 2025
Time: 4:00 PM CET | 10:00 AM EDT | 11:00 PM CST (Asia)
Webinar ID: 898 3237 0697
Webinar Secretariat: journal.webinar@mdpi.com
Meet the Event Chairs
Meet Our Speakers
Dr. Olivia Sgarbura
1. Department of Surgical Oncology, Cancer Institute Montpellier, University of Montpellier, Montpellier, France
2. IRCM, Institut De Recherche en Cancérologie de Montpellier, Inserm U1194 Department, Université De Montpellier, Institut Régional Du Cancer De Montpellier, Montpellier, F-34298, France;
Dr. Olivia Sgarbura is a chief consultant in surgical oncology at the Montpellier Cancer Institute in France. Her clinical and research activity is focused on peritoneal and liver metastases, with a high yearly volume of cytoreductive procedures. In the treatment of peritoneal malignancies, she is experienced with various techniques such as HIPEC, PIPAC, and IP. She is the principal investigator of a phase I (NIPOX) and a phase II randomized trial (MESOTIP) and an associated investigator in many other trials. She was appointed ESPSO (European School of Peritoneal Surface Oncology) mentor after being an international trainer in cytoreductive surgery, HIPEC, and PIPAC on different continents. She currently serves as the vice-president of the SFCO (Francophone Society of Surgical Oncology) and a board member of RENAPE (French National Network of Peritoneal Malignancies) and of the Educational and Training Committee of ESSO. She is the recipient of the Surgical Society of Oncology (SSO) career development exchange award for 2020.
Mr. Gheorghe Potlog
1. Department of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania
2. Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
Dr. Gheorghe Potlog is a General Surgery Specialist and PhD student at the Department of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania. He has participated in more than 100 cytoreductive procedures, including HIPEC, in the management of advanced ovarian cancer and peritoneal carcinomatosis. His doctoral research focuses on “HIPEC—a translational approach between past and future in the personalized treatment of digestive and gynecological cancers.”
In 2023, Dr. Potlog completed a clinical observership at the Center for General and Visceral Surgery at Krankenhaus Barmherzige Brüder, Regensburg, Germany, under the supervision of Prof. Dr. med. Dr. h. c. Pompiliu Piso. He has an active interest in peritoneal surface malignancies and has participated in various international surgical conferences, including meetings of the Peritoneal Surface Oncology Group International (PSOGI).
Asst. Prof. Razvan Grigorie
1. Department of Hepato-Bilio-Pancreatic Surgery, Emergency University Hospital, Bucharest, Romania
2. Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
Dr. Razvan Grigorie is a consultant in General Surgery, with a specialization in oncologic, hepatobiliary, and liver transplantation surgery, and he has participated in and performed a variety of surgical interventions on oncological cases. These include cases of peritoneal carcinomatosis primarily originating from digestive and ovarian cancers, as well as rare instances of primary peritoneal cancers or goblet cell carcinoma. He has also conducted numerous liver resections for liver metastases, predominantly from colorectal cancers. In select cases, the consultant has extended the boundaries of surgical intervention to include oligometastatic liver involvement in gastric or pancreatic cancer, and certain colorectal cancer cases with limited peritoneal carcinomatosis amenable to CCR0 resection. Additionally, the consultant has performed and attended numerous liver transplantation procedures, many of which were indicated for oncological reasons such as hepatocellular carcinoma and rare cases of hemangioendothelioma. The consultant has a specific interest in minimally invasive surgery and is keenly interested in clinical and translational research as well as medical education.
Sponsors and Partners
Organizer
In this section, you will find the recordings of this webinar to watch, re-watch and share with your colleagues!